Silence Therapeutics PLC (SLN) — Long-term Investment Intensity
Silence Therapeutics PLC (SLN) has a Long-term Investment Intensity of 0.2% as of September 2024. Long-term investments of $284.00K represent 0.2% of total assets of $169.38 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See SLN net assets for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Silence Therapeutics PLC Long-term Investment Intensity (2020–2023)
This chart shows how Silence Therapeutics PLC's Long-term Investment Intensity has evolved across 4 annual periods from 2020 to 2023. As of September 2024, the intensity stands at 0.2%, reflecting long-term investments of $284.00K against total assets of $169.38 Million USD. Also explore Silence Therapeutics PLC assets under control for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Silence Therapeutics PLC (2020–2023)
The table below presents the year-by-year Long-term Investment Intensity for Silence Therapeutics PLC from 2020 to 2023, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Silence Therapeutics PLC market capitalisation.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2023 | 0.2% | $284.00K | $119.45 Million | ▼ 0.0 pp |
| 2022 | 0.3% | $284.00K | $107.50 Million | ▼ 0.0 pp |
| 2021 | 0.3% | $301.00K | $96.19 Million | ▼ 0.0 pp |
| 2020 | 0.4% | $303.00K | $85.97 Million | — |